MCI Onehealth Technologies, Inc. Class A (AIDX) Stock Forecast & Price Target

Compare

113 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

AIDX Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

MCI

Onehealth Technologies, Inc. Class A

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

AIDX Stock 12 Month Forecast

Average Price Target

C$3.36

▲(160.47%Upside)

Based on 5 Wall Street analysts offering 12 month price targets for MCI Onehealth Technologies, Inc. Class A in the last 3 months. The average price target is C$3.36 with a high forecast of C$5.00 and a low forecast of C$2.50. The average price target represents a 160.47% change from the last price of C$1.29.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"C$6","-1":"-C$1","0.75":"C$0.75","2.5":"C$2.5","4.25":"C$4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$3.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$2.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2022","6":"Aug<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.45,1.723076923076923,1.9961538461538462,2.269230769230769,2.542307692307692,2.815384615384615,3.088461538461538,3.361538461538461,3.634615384615384,3.907692307692307,4.18076923076923,4.453846153846153,4.726923076923077,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.45,1.596923076923077,1.7438461538461538,1.8907692307692305,2.0376923076923075,2.1846153846153844,2.3315384615384613,2.4784615384615383,2.625384615384615,2.772307692307692,2.919230769230769,3.066153846153846,3.2130769230769225,{"y":3.36,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.45,1.5307692307692307,1.6115384615384616,1.6923076923076923,1.773076923076923,1.853846153846154,1.9346153846153846,2.0153846153846153,2.0961538461538463,2.176923076923077,2.2576923076923077,2.3384615384615386,2.4192307692307695,{"y":2.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.7,"date":1625097600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1627776000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1648771200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1651363200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.69,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.88,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.13,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.59,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.75,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetC$5.00

Average Price TargetC$3.36

Lowest Price TargetC$2.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

C$1

Hold

-22.48%

Downside

Reiterated

06/13/25

Overall, MCI Onehealth Technologies shows strong strategic initiatives and significant expansions, which could improve its market position. However, the current financial performance struggles and technical indicators reflect bearish sentiment and operational inefficiencies, leading to a low overall score. The stock is currently unattractive due to its ongoing losses and negative cash flow, despite potential future upside from strategic corporate events.

Michael W. FreemanRaymond James

Raymond James

C$3

Buy

132.56%

Upside

Reiterated

05/16/25

Raymond James Sticks to Their Buy Rating for MCI Onehealth Technologies, Inc. Class A (AIDX)

Justin KeywoodStifel Nicolaus

Stifel Nicolaus

C$3.8

Buy

194.57%

Upside

Reiterated

05/14/25

MCI Onehealth Technologies, Inc. Class A (AIDX) Gets a Buy from Stifel Nicolaus

Allen KleeMaxim Group

Maxim Group

C$5

Buy

287.60%

Upside

Reiterated

05/14/25

Maxim Group Keeps Their Buy Rating on MCI Onehealth Technologies, Inc. Class A (AIDX)

Kevin KrishnaratneScotiabank

Scotiabank

C$2.5

Buy

93.80%

Upside

Initiated

04/29/25

Scotiabank Starts HealWELL AI Inc (AIDX:CN) at Sector OutperformScotiabank analyst Kevin Krishnaratne initiates coverage on HealWELL AI Inc (AIDX:CN) with a Sector Outperform rating and a price target of Cdn$2.50.

Doug TaylorCanaccord Genuity

Canaccord Genuity

C$2.5

Buy

93.80%

Upside

Initiated

04/24/25

Canaccord Genuity Starts HealWELL AI Inc (AIDX:CN) at Spec. BuyCanaccord Genuity analyst Doug Taylor initiates coverage on HealWELL AI Inc (AIDX:CN) with a Spec. Buy rating and a price target of Cdn$2.50.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

C$1

Hold

-22.48%

Downside

Reiterated

06/13/25

Michael W. FreemanRaymond James

Raymond James

C$3

Buy

132.56%

Upside

Reiterated

05/16/25

Raymond James Sticks to Their Buy Rating for MCI Onehealth Technologies, Inc. Class A (AIDX)

Justin KeywoodStifel Nicolaus

Stifel Nicolaus

C$3.8

Buy

194.57%

Upside

Reiterated

05/14/25

MCI Onehealth Technologies, Inc. Class A (AIDX) Gets a Buy from Stifel Nicolaus

Allen KleeMaxim Group

Maxim Group

C$5

Buy

287.60%

Upside

Reiterated

05/14/25

Maxim Group Keeps Their Buy Rating on MCI Onehealth Technologies, Inc. Class A (AIDX)

Kevin KrishnaratneScotiabank

Scotiabank

C$2.5

Buy

93.80%

Upside

Initiated

04/29/25

Doug TaylorCanaccord Genuity

Canaccord Genuity

C$2.5

Buy

93.80%

Upside

Initiated

04/24/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MCI Onehealth Technologies, Inc. Class A

1 Month

xxx

Success Rate

3/5 ratings generated profit

Average Return

-0.86%

initiated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of -0.86% per trade.

3 Months

xxx

Success Rate

2/5 ratings generated profit

Average Return

-5.20%

initiated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -5.20% per trade.

1 Year

Justin KeywoodStifel Nicolaus

Success Rate

0/7 ratings generated profit

Average Return

-24.89%

reiterated a buy rating 2 months ago

Copying Justin Keywood's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -24.89% per trade.

2 Years

xxx

Success Rate

0/7 ratings generated profit

Average Return

-25.19%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -25.19% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AIDX Analyst Recommendation Trends

Rating

Dec 24

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, AIDX has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AIDX average Analyst price target in the past 3 months is 3.36.

Each month's total comprises the sum of three months' worth of ratings.

AIDX Financial Forecast

AIDX Earnings Forecast

Next quarter’s earnings estimate for AIDX is -C$0.02 with a range of -C$0.04 to -C$0.01. The previous quarter’s EPS was -C$0.08. AIDX beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.17% of the time in the same period. In the last calendar year AIDX has Outperformed its overall industry.

AIDX Sales Forecast

Next quarter’s sales forecast for AIDX is C$38.99M with a range of C$38.00M to C$39.70M. The previous quarter’s sales results were C$14.09M. AIDX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.47% of the time in the same period. In the last calendar year AIDX has Outperformed its overall industry.

AIDX Stock Forecast FAQ

What is TSE:AIDX’s average 12-month price target, according to analysts?

Based on analyst ratings, MCI Onehealth Technologies, Inc. Class A’s 12-month average price target is 3.36.

What is TSE:AIDX’s upside potential, based on the analysts’ average price target?

MCI Onehealth Technologies, Inc. Class A has 160.47% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TSE:AIDX a Buy, Sell or Hold?

MCI Onehealth Technologies, Inc. Class A has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is MCI Onehealth Technologies, Inc. Class A’s price target?

The average price target for MCI Onehealth Technologies, Inc. Class A is 3.36. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$5.00 ,the lowest forecast is C$2.50. The average price target represents 160.47% Increase from the current price of C$1.29.

What do analysts say about MCI Onehealth Technologies, Inc. Class A?

MCI Onehealth Technologies, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of TSE:AIDX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

MCI Onehealth Technologies, Inc. Class A (AIDX) Stock Forecast & Price Target

AIDX Analyst Ratings

AIDX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering MCI Onehealth Technologies, Inc. Class A

AIDX Analyst Recommendation Trends

AIDX Financial Forecast

AIDX Earnings Forecast

AIDX Sales Forecast

AIDX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts